) recently revealed the takeover of U.K. Medical Limited, a
distributor of medical offerings to the private health sector in
the U.K. as well as the National Health Service ("NHS") of that
country. U.K. Medical, however, mainly catered to the NHS and
distributed many one-time-use medical offerings used in surgery,
biopsy, gynecology, obstetrics, drainage, cardiac and other
functions. CareFusion did not provide information on the terms of
This takeover bolsters CareFusion's role in the U.K. where it
has already created a leadership position for itself in infection
prevention and infusion therapy. This acquisition is a natural
outcome of the long-standing cooperation between CareFusion and
U.K. Medical. With this takeover, CareFusion is in a stronger
position to harness its clinical expertise in that country.
U.K. Medical is CareFusion's fifth takeover, integral to its
strategy to grow in the global markets. The U.K.-based distributor
enjoyed robust client relationships and clinical know-how on latest
medical technologies, including offerings used in acute-care
U.K. Medical was the only distributor in the U.K. of
CareFusion's Interventional Technologies set up. Furthermore, it
has been a major contributor to growth in CareFusion's
Interventional Technologies business.
For its part, U.K. Medical expressed the hope that, as part of
CareFusion, it would continue to serve the medical industry of the
U.K. with top class medical offerings.
CareFusion is a global company catering to the health care
industry with offerings that enable hospitals enhance the safety
and quality of care. Following the spin-off of CareFusion a few
years ago, the new
) and CareFusion businesses began to trade in the bourses.
CARDINAL HEALTH (CAH): Free Stock Analysis
CAREFUSION CORP (CFN): Free Stock Analysis
To read this article on Zacks.com click here.